Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
169 hedge funds and large institutions have $907M invested in Avid Bioservices, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 16 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 57
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
1% more funds holding
Funds holding: 168 → 169 (+1)
9% less call options, than puts
Call options by funds: $833K | Put options by funds: $918K
25% less capital invested
Capital invested by funds: $1.21B → $907M (-$304M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.08M |
| 2 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$7.25M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$6.67M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.31M |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$4.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.8M |
| 2 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$9.21M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.35M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.12M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$4.71M |
CDMO Hedge Fund Activity: Q2 2023 in Review
169 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2023, worth a combined $907M — down 25% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CDMO positions and 16 closed out — a net gain of 1 holder — while 65 added to existing stakes and 57 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $8.08M. The largest seller was Fidelity Investments, cutting an estimated $13.8M.
- 169 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2023, up from 168 in Q1 2023.
- Funds reported $907M of Avid Bioservices, Inc. Common Stock stock for Q2 2023, down 25% quarter-over-quarter.
- 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2023 and 16 closed out, a net change of +1 holder.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2023 was Royal Bank of Canada, an estimated $8.08M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2023 was Fidelity Investments, an estimated $13.8M sold.
Based on aggregated 13F filings for Q2 2023.